Lannett (LCI) – Lawsuits Will Wipe Out The Equity" Citron Research

Lannett will be the First Pharma Company to go Bankrupt amid Continuing Drug Pricing Scrutiny If Even Modest Price Cuts Hit Either of Lannett’s Cash Cow Drugs, It Will Violate Its Debt Covenants  $13-$15 Near Term Target Equity Worthless Over Long-Term Over the past year, almost every media outlet in the US has dissected the pharmaceutical industry to expose the culprits of rampant opportunistically driven price gouging. We are now well past that point. The next question investors will have to ask is: “Which companies will collapse under their debt load from levered acquisitions, based on the assumption of endless…